Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Glaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging po...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2016/6509809 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832560335607824384 |
---|---|
author | Paul Harasymowycz Catherine Birt Patrick Gooi Lisa Heckler Cindy Hutnik Delan Jinapriya Lesya Shuba David Yan Radmila Day |
author_facet | Paul Harasymowycz Catherine Birt Patrick Gooi Lisa Heckler Cindy Hutnik Delan Jinapriya Lesya Shuba David Yan Radmila Day |
author_sort | Paul Harasymowycz |
collection | DOAJ |
description | Glaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging population it is expected that the prevalence of glaucoma will continue to increase. Despite recent advances in imaging and visual field testing techniques that allow establishment of earlier diagnosis and treatment initiation, significant numbers of glaucoma patients are undiagnosed and present late in the course of their disease. This can lead to irreversible vision loss, reduced quality of life, and a higher socioeconomic burden. Selection of therapeutic approaches for glaucoma should be based on careful ocular examination, patient medical history, presence of comorbidities, and awareness of concomitant systemic therapies. Therapy should also be individualized to patients’ needs and preferences. Recent developments in this therapeutic field require revisiting treatment algorithms and integration of traditional and novel approaches in order to ensure optimal visual outcomes. This article provides an overview of recent developments and practice trends in the medical management of glaucoma in Canada. A discussion of the surgical management is beyond the scope of this paper. |
format | Article |
id | doaj-art-ab468653c3ee4cd78bf0245438a946b9 |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-ab468653c3ee4cd78bf0245438a946b92025-02-03T01:27:52ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/65098096509809Medical Management of Glaucoma in the 21st Century from a Canadian PerspectivePaul Harasymowycz0Catherine Birt1Patrick Gooi2Lisa Heckler3Cindy Hutnik4Delan Jinapriya5Lesya Shuba6David Yan7Radmila Day8Université de Montréal, Montreal, QC, CanadaUniversity of Toronto, Toronto, ON, CanadaUniversity of Calgary, Calgary, AB, CanadaUniversité de Montréal, Montreal, QC, CanadaWestern University, London, ON, CanadaQueen’s University, Kingston, ON, CanadaDalhousie University, Halifax, NS, CanadaUniversity of Toronto, Toronto, ON, CanadaSNELL Medical Communication Inc., Montreal, QC, CanadaGlaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging population it is expected that the prevalence of glaucoma will continue to increase. Despite recent advances in imaging and visual field testing techniques that allow establishment of earlier diagnosis and treatment initiation, significant numbers of glaucoma patients are undiagnosed and present late in the course of their disease. This can lead to irreversible vision loss, reduced quality of life, and a higher socioeconomic burden. Selection of therapeutic approaches for glaucoma should be based on careful ocular examination, patient medical history, presence of comorbidities, and awareness of concomitant systemic therapies. Therapy should also be individualized to patients’ needs and preferences. Recent developments in this therapeutic field require revisiting treatment algorithms and integration of traditional and novel approaches in order to ensure optimal visual outcomes. This article provides an overview of recent developments and practice trends in the medical management of glaucoma in Canada. A discussion of the surgical management is beyond the scope of this paper.http://dx.doi.org/10.1155/2016/6509809 |
spellingShingle | Paul Harasymowycz Catherine Birt Patrick Gooi Lisa Heckler Cindy Hutnik Delan Jinapriya Lesya Shuba David Yan Radmila Day Medical Management of Glaucoma in the 21st Century from a Canadian Perspective Journal of Ophthalmology |
title | Medical Management of Glaucoma in the 21st Century from a Canadian Perspective |
title_full | Medical Management of Glaucoma in the 21st Century from a Canadian Perspective |
title_fullStr | Medical Management of Glaucoma in the 21st Century from a Canadian Perspective |
title_full_unstemmed | Medical Management of Glaucoma in the 21st Century from a Canadian Perspective |
title_short | Medical Management of Glaucoma in the 21st Century from a Canadian Perspective |
title_sort | medical management of glaucoma in the 21st century from a canadian perspective |
url | http://dx.doi.org/10.1155/2016/6509809 |
work_keys_str_mv | AT paulharasymowycz medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT catherinebirt medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT patrickgooi medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT lisaheckler medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT cindyhutnik medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT delanjinapriya medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT lesyashuba medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT davidyan medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective AT radmiladay medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective |